Med. praxi. 2024;21(2):96-99 | DOI: 10.36290/med.2024.005

Bipolar radiofrequency-induced thermotherapy of haemorrhoids: a 10-year experience

MUDr. Jiří Duben, Ph.D.

Chirurgické oddělení, EUC klinika Zlín

Výsledky: Od 9/2007 do 1/2017 jsme na našem oddělení provedli 228 operací RFITTH u 217 pacientů. V souboru bylo 134 mužů a 94 žen, průměrný věk v souboru byl 51 let. Ve stadiu III bylo provedeno 107 operací. Ve stadiu IV bylo provedeno 121 operací. Komplikace pooperační fisury se vyskytly u 20 pacientů (8,7 %). Trombotizovaný uzel u 6 pacientů (2,6 %). Hyperspasmus svěračů u 9 pacientů (3,9 %). Prolaps konečníku se objevil u 4 pacientů (1,7 %). Recidivy: v souboru pacientů bylo provedeno 10 reoperací pomocí RFITTH u 9 pacientů (3,9 %).

Závěr: Metoda je bezpečnou miniinvazivní variantou léčby vyšších stadií hemoroidální nemoci.

Introduction: Bipolar radiofrequency-induced thermotherapy of advanced stage haemorrhoid disease has been used successfully at the EUC Clinic in Zlin for ten years.

Method: RFITTH is bipolar radiofrequency-induced thermotherapy of haemorrhoidal diseases. High frequency electric current causes thermal coagulation of tissue. The procedure results in the elimination or significant reduction of prolapse and bleeding of hemorrhoids.

Results: 228 RFITTH procedures were performed in 217 patients at the Department of Surgery at the Atlas Hospital from 9/2007 to 1/2017. The group consisted of 134 men and 94 women, the average age was 51 years. 107 operations were performed in stage III and 121 in stage IV. Complications of the procedure involved postoperative fissure occurring in 20 patients (8.7 %). Thrombotic haemorrhoid developed in 6 patients (2.6 %), hyperspasm of the sphincters in 9 patients (3.9 %). Prolapse of the rectal mucosa was diagnosed in 4 patients (1.7 %). The disease recurred in 9 patients and 10 reoperations were performed (3.9 %).

Conclusion: The method is a safe miniinvasive therapeutic option for advanced stage haemorrhoidal disease.

Keywords: RFITTH, haemorrhoidal disease, radiofrequency coagulation.

Received: October 2, 2023; Accepted: February 13, 2024; Published: May 17, 2024  Show citation